Sponsorship & Exhibition

As one of the premier international leukaemia conferences, NDLR 2022 will again bring together early career investigators and senior scientists and clinicians. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, forging new collaborations.

Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR Meeting offers a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field and therefore offers sponsoring organisations unrivalled exposure and recognition.

For any enquiries please contact our Meeting Managers on 02 9265 0700 or email ndlr@arinex.com.au



Thank you to our Sponsors


NDLR 2022 Meeting Supporter



Principal Sponsors



Bronze Sponsors


Welcome Reception Sponsor



Scientific Poster Sponsor

Notepad & Pen Sponsor

Catering Break Sponsor



New Investigator Forum Sponsor


Confirmed Exhibitors 


The Australasian Leukaemia & Lymphoma Group (ALLG) is the only not-for-profit co-operative clinical trials group representing Australian and New Zealand haematologists, dedicated to researching better treatments for people with blood cancer. The ALLG sponsors local investigator initiated clinical trials to improve lives, advance research knowledge and standard clinical practice. www.allg.org.au

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology.

For more information, please visit: www.astrazeneca.com

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb Australia, visit us at BMS.com/au.

HaemHQ is your new BMS Australia digital hub for Multiple Myeloma information and resources.  Register with HaemHQ.com.au to access and explore resources including clinical data, PBS codes and forms, short videos from your peers discussing current considerations in myeloma, patient materials and our interactive treatment sequencer.

Integrated Sciences

Integrated Sciences, established in 1983, specialises in the sale and support of Clinical Diagnostics, Molecular Diagnostics, Point of Care and Research products in Australia and New Zealand. We pride ourselves in offering quality products with the highest levels of technical support and service. We have partnered with Mission Bio a life sciences company that accelerates discoveries and cures by equipping researchers with the tools they need to improve how we measure and predict resistance and response to precision therapies. With the Tapestri Platform, the only commercialised platform capable of analysing DNA and protein simultaneously with single-cell resolution, Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health.


At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access to ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.


At Lonza, we deliver technologies to enable a healthier world. We provide life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release.

Lonza’s Bioscience products and services range from cell culture and discovery technologies for research, to quality-control tests and software for biomanufacturing.


One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer and to deliver on our purpose: breakthroughs that change patients’ lives.